Bio-Techne Corp
Organization details
- Legal name
- Bio-Techne Corp
- Former names
- Techne Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Minnesota
- Headquarters city
- Minneapolis
- Headquarters state / province
- Minnesota
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- TECH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000842023
- EIN
- 41-1427402
Board of directors
-
Alpna Seth · DirectorSince 2023
-
Amy E. Herr · DirectorSince 2025
-
Charles R. Kummeth · Director · Chief Executive OfficerSince 2023
-
John L. Higgins · DirectorSince 2023
-
Joseph D. Keegan · DirectorSince 2023
-
Judith Klimovsky V · DirectorSince 2024
-
Julie L. Bushman · DirectorSince 2023
-
Kim Kelderman · Director · Chief Executive OfficerSince 2024
-
Randolph C. Steer · DirectorSince 2023
-
Robert Baumgartner V · DirectorSince 2023
-
Roeland Nusse · DirectorSince 2023
-
Rupert Vessey · DirectorSince 2023
Chief executives
Director election results
Annual meeting of October 30, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.3%
-
95.8%
-
96.1%
-
96.8%
-
96.9%
-
97.8%
-
98.5%
-
99.1%
-
99.2%
Board connections
6 of this board's directors also sit on 10 other boards. 6 are in the same sector.
- via Julie L. Bushman
-
CONMED Corporation Same sectorvia Kim Kelderman
-
Dr. Reddy's Laboratories Ltd Same sectorvia Alpna Seth
-
Generate Biomedicines Inc. Same sectorvia Rupert Vessey
- via Charles R. Kummeth
-
Keros Therapeutics Inc. Same sectorvia Alpna Seth
-
OmniAb Inc. Same sectorvia John L. Higgins
-
Orthofix Medical Inc. Same sectorvia Charles R. Kummeth
- via Julie L. Bushman
- via Charles R. Kummeth
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $437,187
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | Hippel James Officer (CFO) | Option exercise | +11,545 | — | — |
| Nov 1, 2026 | Kim Kelderman Director, Officer (Chief Executive Officer) | Shares withheld for tax | −2,385 | $72.66 | $173,294 |
| Nov 1, 2026 | Hippel James Officer (CFO) | Shares withheld for tax | −5,096 | $72.66 | $370,275 |
| Oct 29, 2026 | Robert Baumgartner V Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | Julie L. Bushman Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | John L. Higgins Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | Joseph D. Keegan Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | Amy E. Herr Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | Judith Klimovsky V Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | Alpna Seth Director | Grant or award | +2,750 | — | — |
| Oct 29, 2026 | Rupert Vessey Director | Grant or award | +2,750 | — | — |
| Sep 28, 2026 | John L. Higgins Director | Option exercise | +15,940 | — | — |
| Sep 28, 2026 | John L. Higgins Director | Shares withheld for tax | −5,562 | $72.51 | $403,301 |
| Sep 22, 2026 | Robert Baumgartner V Director | Option exercise | +15,940 | — | — |
| Sep 22, 2026 | Robert Baumgartner V Director | Shares withheld for tax | −5,559 | $72.55 | $403,305 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Bio-Techne Corp
Who is the CEO of Bio-Techne Corp?
Charles R. Kummeth is Bio-Techne Corp's Chief Executive Officer.
How many directors are on Bio-Techne Corp's board?
Bio-Techne Corp's board has 12 directors: Alpna Seth, Amy E. Herr, Charles R. Kummeth, John L. Higgins, Joseph D. Keegan, Judith Klimovsky V, Julie L. Bushman, Kim Kelderman, Randolph C. Steer, Robert Baumgartner V and 2 others.
Are Bio-Techne Corp insiders buying or selling shares?
Over the last 12 months, Bio-Techne Corp insiders made no open-market purchases and sold $437,187 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="bio-techne-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.